DIREVO Announces Incorporation of Industrial Biotechnology Subsidiary
DIREVO Biotech AG announced the incorporation of a fully owned subsidiary named DIREVO Industrial biotechnology GmbH. The new company was formed to spin-out DIREVO's industrial biotechnology business unit established at the beginning of 2007 and the recently acquired AC Biotec GmbH. The new company focuses on food & Feed and Biorefinery markets and provides solutions through discovery, development and scale up of enzymes and strains. It develops products both independently and with global leaders such as Danisco/Genencor and Nestlé. The collaboration with Danisco A/S, for instance, has yielded a significantly improved enzyme which is marketed as part of a Danisco/Genencor product.
The company will be lead by Mr. Anindya Mukherjee, who joined DIREVO from DSM in the year 2007, and Dr. Hans-Günter Brünker, who joined DIREVO coming from amaxa AG beginning of the year 2008. Additional members of the senior management team are Dr. Henrik Moellgaard as Head of R&D, who joined from Christian Hansen in 2007, and Dr. Simon Curvers, Managing Director of AC Biotec GmbH that was acquired in 2007.
"This is an important milestone in DIREVO's history, because it maximizes our long-term growth potential by improving the chances for the successful development of both DIREVO Industrial Biotechnology GmbH and DIREVO Biotech AG" said Dr. Thomas von Rüden, CEO of DIREVO Biotech AG. "This allows the two companies to focus on their respective core businesses."
The company will start its operations with a total of 17 full-time employees and will seek new investors for building up its infrastructure as well as to secure its long-term growth.
Other news from the department business & finance
